I don't get why you continued to argue with me when I said wheezo was always a small niche market just because you held the stock. RSH already received regulatory approval for previous version of wheezo many years ago and failed to commercialise this to the small niche market so why are you surprise they are having the same issue with the latest version of wheezo and using the same face of the product in Michael Clarke with the previous version?
Ann: Preliminary Final Report, page-36
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.002(7.41%) |
Mkt cap ! $31.41M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.5¢ | $47.02K | 1.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 999999 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 292868 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RSH (ASX) Chart |